|
The following were reviewed as part of this investigation: patient severity, applicable previous investigation(s), sample analysis, applicable fmea documents, labeling, and applicable manufacturing records.Based on a review of this information, the following was concluded: the complaint that the implicated product caused or contributed to the reported patient death was inconclusive due to the nature of the complaint and the evidence provided for investigation.Three unopened trays from the implicated lot were provided for investigation.A visual observation revealed that each tray was sealed and no breaches were observed in the sterile barrier.No damage or defects were observed on the kit components through the packaging material.One package was opened and a visual observation of each component revealed nothing remarkable.A microscopic examination of the catheter shaft revealed nothing remarkable.A functional test of the device revealed nothing remarkable.It was reported that a few hours after picc insertion the patient died.The complainant reported that the patient death is due to heart disease and unrelated to picc placement.The complainant also reported an uncomplicated basilica placement in the ir suite under fluoroscopy.Patient reportedly developed dyspnea and a rash and coded two hours after picc placement.A review of the manufacturing records showed that the lot met all release criteria and no evidence was found that linked the reported event to the manufacturing process.The ifu states, the device is contraindicated whenever: the presence of device-related infection, bacteremia, or septicemia is known or suspected.The patients body size is insufficient to accommodate the size of the implanted device.The patient is known or is suspected to be allergic to materials contained in the device.Past irradiation of prospective insertion site.Previous episodes of venous thrombosis or vascular surgical procedures at the prospective placement site.Local tissue factors will prevent proper device stabilization and/or access.The ifu also states, the potential exists for serious complications including the following: hypersensitivity, anaphylactic or anaphylactic-like reaction during placement, positioning, flushing of catheter or cleaning of catheter exit site." a lot history review (lhr) of recx0547 showed two other similar product complaint(s) from this lot number.The complaints for this lot number (recx0547) have been reported from the same facility in (b)(6).
|